1. Inicio
  2. Publicaciones
  3. The European Society of Cardiology quality indicators in atrial fibrillation in centers of excellence in Spain: the SEC-EXCELENTE FA registry;

The European Society of Cardiology quality indicators in atrial fibrillation in centers of excellence in Spain: the SEC-EXCELENTE FA registry;

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Ruiz Ortiz M.
  • Arbelo E.
  • Roldán Rabadán I.
  • Marín F.
  • Pérez Cabeza A.
  • Marzoa Rivas R.
  • Valle Alberca A.
  • Ibáñez Criado A.
  • Valle Muñoz A.
  • del Río Lechuga A.
  • Elola Somoza F.J.
  • Anguita Sánchez M.
  • Peinado Peinado R.
  • Arbelo Laínez E.
  • Río Lechuga A.D.

Grupos

Abstract

Introduction and objectives: By 2022, 9 centers had been accredited by the Spanish Society of Cardiology for the atrial fibrillation (AF) process. Our objective was to evaluate the performance of these centers based on the quality indicators (QIs) proposed by the European Society of Cardiology (ESC) in 2020. Methods: Adults with AF who were attended in the cardiology departments of participating centers during the second week of May 2019 were included in a retrospective registry (n = 797, age 72 ± 11 years, 60% male). Key ESC QIs were assessed. Results: CHA2DS2-VASc, HAS-BLED scores, and serum creatinine levels were documented in 24.9%, 6.1%, and 96.2% of patients, respectively. Anticoagulation was appropriately prescribed in 90.6% of high-risk patients according to the CHA2DS2-VASc score, but was inappropriately prescribed in 57.8% of low-risk patients. Among all patients, 84.1% received high-quality anticoagulation. Inappropriate antiarrhythmic drugs were prescribed in 7.2% of patients with permanent AF, 2.9% of those with structural heart disease, and 0.0% of those with end-stage kidney disease. Catheter ablation was offered to 70% of patients with symptomatic paroxysmal or persistent AF after the failure or intolerance of 1 antiarrhythmic drug. All modifiable risk factors were documented in 59.3% of patients. Rates of all-cause mortality, ischemic stroke or transient ischemic attack, and major bleeding were 8.1, 0.8, and 2.56 per 100 patients/y, respectively. QIs for anticoagulation and outcomes were similar between general cardiology and tertiary referral centers. Conclusions: Although accredited centers in Spain demonstrated good performance in many of the ESC QIs for AF, there remains room for improvement. These data could serve as a starting point for enhancing the quality of care in this population. © 2024 Sociedad Española de Cardiología

Datos de la publicación

ISSN/ISSNe:
0300-8932, 1579-2242

REVISTA ESPANOLA DE CARDIOLOGIA  EDICIONES DOYMA S A

Tipo:
Article
Páginas:
389-400
PubMed:
39303807
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,407 SCImago ℠
Cuartil:
Q3 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Aged; Anticoagulants; Atrial Fibrillation; Cardiology; Female; Humans; Male; Middle Aged; Quality Indicators, Health Care; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Societies, Medical; Spain; Stroke; antiarrhythmic agent; anticoagulant agent; accreditation; aged; all cause mortality; anticoagulation; Article; atrial fibrillation; catheter ablation; CHA2DS2-VASc score; controlled study; creatinine blood level; end stage renal disease; female; HAS BLED score; health care quality; heart disease; high risk patient; human; ischemic stroke; low risk patient; major bleeding; major clinical study; male; medical society; observational study; performance; register; retrospective study; risk factor; Spain; transient ischemic attack; atrial fibrillation; cardiology; cerebrovascular accident; clinical trial; complication; epidemiology; etiology; middle aged; multicenter study; prevention and control; risk assessment; Spain; therapy

Campos de Estudio

Cita

Compartir